COSCIENS Biopharma Inc

Explore COSCIENS Biopharma’s journey in oncology and endocrinology, its stock volatility, and research-driven growth prospects in the evolving biotech market.

COSCIENS Biopharma Inc. has reconstituted its board of directors with experienced leaders to enhance shareholder value and improve governance, following a resolution agreement with activist investor Goodwood Inc.

COSCIENS Biopharma Inc. is facing a potential leadership shake-up as its board reviews nominations from Goodwood, a move that could significantly impact the company’s future direction.